Evox Therapeutics Ltd Email Format

Research ServicesEngland, United Kingdom11-50 Employees

Evox Therapeutics Ltd operates in the field of exosome-based therapeutics as a research-focused biotechnology company. It aims to harness the natural trafficking properties of extracellular vesicles to deliver nucleic acids and proteins as therapeutic cargo. The company is building a modular platform intended to enable the clinical translation of exosome-based therapeutics across a broad range of diseases.

Based in Oxford, Evox was founded in 2016 by researchers from Oxford University and the Karolinska Institutet. It maintains a comprehensive intellectual property portfolio covering exosome-based delivery, targeting technology, and proprietary manufacturing and purification methods to support clinical development across disease areas. In February 2026, Evox announced a collaboration with the Rett Syndrome Research Trust to assess the feasibility of using its ExoEdit exosome-based delivery platform for a Rett syndrome gene-editing therapy.

Sign up for free to view info

Company overview Employee directory